Showing results (101-110 of 144) with videos related to

Sort By:
Pageof 15
Therapeutic Drug Monitoring|January 1, 1989
Aminoglycoside dosing in pediatric patientsB C Carlstedt, M Uaamnuichai, R B Day, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1983
Ceftriaxone distribution between maternal blood and fetal blood and tissues at parturition and between blood and milk postpartumD A Kafetzis, D C Brater, J E Fanourgakis, et al.
Clinical Pharmacology and Therapeutics|March 6, 2009
Factors associated with exacerbation of heart failure include treatment adherence and health literacy skillsM D Murray, W Tu, J Wu, et al.
British Journal of Clinical Pharmacology|May 1, 1994
Methotrexate disposition following concomitant administration of ketoprofen, piroxicam and flurbiprofen in patients with rheumatoid arthritisT S Tracy, T Worster, J D Bradley, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1981
Clinical pharmacology of cefotaxime in pediatric patientsD A Kafetzis, D C Brater, J Kanarios, et al.
Kidney International|August 1, 1982
Absorption and disposition of furosemide in congestive heart failureD C Brater, R Seiwell, S Anderson, et al.
European Journal of Clinical Pharmacology|January 1, 1982
Clinical pharmacology of etintidine in patients with duodenal ulcerD C Brater, W M Meyers, K A Dandekar, et al.
British Journal of Clinical Pharmacology|September 6, 2000
Intravenous diltiazem and CYP3A-mediated metabolismA L Masica, N E Azie, D C Brater, et al.
The American Journal of the Medical Sciences|April 1, 1990
Ibuprofen-associated renal impairment in a large general internal medicine practiceM D Murray, D C Brater, W M Tierney, et al.
Pharmacotherapy|January 1, 1997
Variable furosemide absorption and poor predictability of response in elderly patientsM D Murray, K M Haag, P K Black, et al.
Pageof 15